Header Logo

First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report.

First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report. Eur J Cancer. 2001 Jan; 37 Suppl 1:25-29.

View in: PubMed